LB PHARMACEUTICALS INC — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | — | Purchase | 666,666 | $15.00 | $9,999,990 | 666,666 | Sep 12, 2025 |
| Pontifax Management 4 G.P. (2015) Ltd. | — | Purchase | 1,000,000 | $15.00 | $15,000,000 | 1,411,681 | Sep 12, 2025 |
| Nussbaum Ran | — | Purchase | 1,000,000 | $15.00 | $15,000,000 | 1,411,681 | Sep 12, 2025 |
| Vida Ventures GP III, L.L.C. | — | C | 1,262 | — | — | 1,262 | Sep 12, 2025 |